drugset / Trial / NCT05500482
Vellore Typhoid Vaccine Impact Trial
Phase 4
Completed
72400 enrolled
Christian Medical College, Vellore, India
Bill and Melinda Gates Foundation · collabImperial College London · collabUniversity College, London · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This cluster randomised trial will examine the impact of introducing TyphiBEV, a typhoid conjugate vaccine licensed in India, on the incidence of typhoid fever in a high burden urban setting in South India.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2026-01-31
- Completion
- 2026-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TYPHIBEV | Vaccine | 0.5 ml | Intramuscular |